Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.51% |
| 2 | Consumer Discretionary | 7.62% |
| 3 | Energy | 7.06% |
| 4 | Technology | 6.57% |
| 5 | Industrials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OKS
5351
DELISTED
Oneok Partners LP
OKS
| $83K | ﹤0.01% |
1,573
+590
| +60% | +$29.9K |
|
|
COWN
5352
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $83K | ﹤0.01% |
6,027
+1,625
| +37% | +$21.7K |
|
|
COCO
5353
PUT
DELISTED
CORINTHIAN COLLEGES INC
COCO
| $83K | ﹤0.01% |
38,100
+11,000
| +41% | +$25.5K |
|
|
STSI
5354
CALL
DELISTED
STAR SCIENTIFIC INC
STSI
| $83K | ﹤0.01% |
43,300
-7,200
| -14% | -$13.6K |
|
|
ZOLT
5355
PUT
DELISTED
ZOLTEK COMPANIES INC
ZOLT
| $83K | ﹤0.01% |
5,000
+4,400
| +733% | +$62.7K |
|
5356
PUT
Brink's
BCO
$4.72B
| $82K | ﹤0.01% |
2,900
-2,500
| -46% | -$68K |
|
5357
PUT
Dana Inc
DAN
$3.26B
| $82K | ﹤0.01% |
3,600
-5,400
| -60% | -$117K |
|
5358
PUT
Mercury Insurance
MCY
$5.81B
| $82K | ﹤0.01% |
1,700
-1,400
| -45% | -$63.2K |
|
5359
PUT
Regency Centers
REG
$14.1B
| $82K | ﹤0.01% |
1,700
-300
| -15% | -$15.1K |
|
|
TEN
5360
Tsakos Energy Navigation Ltd
TEN
$1.23B
| $82K | ﹤0.01% |
3,167
-16,298
| -84% | -$405K |
|
|
ACC
5361
CALL
DELISTED
American Campus Communities, Inc.
ACC
| $82K | ﹤0.01% |
2,400
-2,500
| -51% | -$93.4K |
|
|
ACC
5362
PUT
DELISTED
American Campus Communities, Inc.
ACC
| $82K | ﹤0.01% |
2,400
-1,500
| -38% | -$56K |
|
5363
PUT
Allot
ALLT
$388M
| $81K | ﹤0.01% |
6,400
-2,400
| -27% | -$32K |
|
5364
PUT
Frontline
FRO
$9.02B
| $81K | ﹤0.01% |
6,100
+3,620
| +146% | +$45.4K |
|
5365
CALL
Huntington Ingalls Industries
HII
$12.8B
| $81K | ﹤0.01% |
1,200
-1,400
| -54% | -$89.3K |
|
5366
PUT
Integra LifeSciences
IART
$1.42B
| $81K | ﹤0.01% |
4,893
+2,447
| +100% | +$39.3K |
|
5367
CALL
Logitech
LOGI
$15B
| $81K | ﹤0.01% |
9,200
+3,800
| +70% | +$28.4K |
|
5368
CALL
Novavax
NVAX
$1.34B
| $81K | ﹤0.01% |
1,285
+995
| +343% | +$56K |
|
5369
Oxford Square Capital
OXSQ
$160M
| $81K | ﹤0.01% |
+8,265
| New | +$81.1K |
|
5370
Sarepta Therapeutics
SRPT
$1.95B
| $81K | ﹤0.01% |
1,705
-99,089
| -98% | -$3.82M |
|
5371
CVR Partners
UAN
$1.26B
| $81K | ﹤0.01% |
458
-84
| -15% | -$17K |
|
|
TGA
5372
CALL
DELISTED
Transglobe Energy Corp
TGA
| $81K | ﹤0.01% |
10,300
+8,200
| +390% | +$55.9K |
|
|
JE
5373
PUT
DELISTED
Just Energy Group Inc
JE
| $81K | ﹤0.01% |
+385
| New | +$83.2K |
|
|
MOVE
5374
CALL
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $81K | ﹤0.01% |
+4,800
| New | +$69.3K |
|
5375
CALL
Calix
CALX
$2.51B
| $80K | ﹤0.01% |
6,300
+1,800
| +40% | +$22K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.